Third Annual PMO Live Conference
The final day of the Third Annual PMO Live Conference, a Global Biomarkers Consortium Initiative, opened with a review of yesterday’s presentations and a preview of today’s talks by the meeting’s co-chair, Dr. Jorge Cortes. He stressed the multidisciplinary nature of the day’s proceedings that makes PMO Live unique among molecular biomarker/personalized medicine conferences.
The Third Annual PMO Live Conference, a Global Biomarkers Consortium Initiative, opened today with a record turnout. More than 100 registrants were welcomed by Dr. Roy Herbst, Chief of Medical Oncology at the Yale Comprehensive Cancer Center, one of the Congress co-chairs. Dr. Herbst provided an overview of the exciting new developments in the molecular pathophysiology and personalized therapy of cancer, and laid out the goals of the meeting.